ICU Fundamental Analysis - SEASTAR MEDICAL HOLDING CORP

Fundamental Rating

We assign a fundamental rating of 2 out of 10 to ICU. ICU was compared to 188 industry peers in the Health Care Equipment & Supplies industry. The financial health of ICU is average, but there are quite some concerns on its profitability. ICU is valied quite expensively at the moment, while it does show a decent growth rate.

Quickly go to:

1. Profitability

1.1 Basic Checks

ICU had negative earnings in the past year.

In the past year ICU has reported a negative cash flow from operations.

ICU had negative earnings in each of the past 5 years.

ICU had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

ICU has a Return On Assets of -209.36%. This is amonst the worse of the industry: ICU underperforms 93.09% of its industry peers.

Looking at the Return On Equity, with a value of -2815.04%, ICU is doing worse than 92.02% of the companies in the same industry.

		Industry Rank	Sector Rank
ROA	-209.36%
ROE	-2815.04%
ROIC	N/A

ROA(3y)-587.39%

ROA(5y)-528.31%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

With a Gross Margin value of 31.54%, ICU is not doing good in the industry: 73.94% of the companies in the same industry are doing better.

The Profit Margin and Operating Margin are not available for ICU so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	31.54%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

Compared to 1 year ago, ICU has more shares outstanding

ICU has a better debt/assets ratio than last year.

2.2 Solvency

ICU has an Altman-Z score of -32.97. This is a bad value and indicates that ICU is not financially healthy and even has some risk of bankruptcy.

ICU has a worse Altman-Z score (-32.97) than 93.62% of its industry peers.

ICU has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Altman-Z	-32.97

ROIC/WACCN/A

WACCN/A

2.3 Liquidity

A Current Ratio of 0.96 indicates that ICU may have some problems paying its short term obligations.

Looking at the Current ratio, with a value of 0.96, ICU is doing worse than 90.43% of the companies in the same industry.

A Quick Ratio of 0.96 indicates that ICU may have some problems paying its short term obligations.

ICU's Quick ratio of 0.96 is on the low side compared to the rest of the industry. ICU is outperformed by 78.72% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	0.96
Quick Ratio	0.96

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 86.78% over the past year.

EPS 1Y (TTM)86.78%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%90.74%

Revenue 1Y (TTM)N/A

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%N/A

3.2 Future

The Earnings Per Share is expected to grow by 36.61% on average over the next years. This is a very strong growth

ICU is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 223.69% yearly.

EPS Next Y80.14%

EPS Next 2Y36.61%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next Year423.66%

Revenue Next 2Y223.69%

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

ICU reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

Also next year ICU is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

ICU's earnings are expected to grow with 36.61% in the coming years. This may justify a more expensive valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y36.61%

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

ICU does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

SEASTAR MEDICAL HOLDING CORP

NASDAQ:ICU (6/11/2025, 8:00:02 PM)

After market: 1.23 -0.01 (-0.81%)

1.24

-0.01 (-0.8%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupHealth Care Equipment & Services

GICS IndustryHealth Care Equipment & Supplies

Earnings (Last)05-14 2025-05-14/amc

Earnings (Next)08-11 2025-08-11

Inst Owners2.52%

Inst Owner Change120.88%

Ins Owners1.11%

Ins Owner Change0.13%

Market Cap13.09M

Analysts80

Price Target7.14 (475.81%)

Short Float %1.09%

Short Ratio0.64

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)1

Avg EPS beat(2)8.05%

Min EPS beat(2)-0.12%

Max EPS beat(2)16.22%

EPS beat(4)3

Avg EPS beat(4)11.85%

Min EPS beat(4)-0.12%

Max EPS beat(4)27.67%

EPS beat(8)3

Avg EPS beat(8)-12.38%

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)1

Avg Revenue beat(2)18.81%

Min Revenue beat(2)-55.78%

Max Revenue beat(2)93.4%

Revenue beat(4)1

Avg Revenue beat(4)-18.15%

Min Revenue beat(4)-100%

Max Revenue beat(4)93.4%

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)0%

EPS NQ rev (1m)-7.5%

EPS NQ rev (3m)27.12%

EPS NY rev (1m)0%

EPS NY rev (3m)28.84%

Revenue NQ rev (1m)0%

Revenue NQ rev (3m)0%

Revenue NY rev (1m)14.16%

Revenue NY rev (3m)14.16%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	30.59
P/FCF	N/A
P/OCF	N/A
P/B	23.18
P/tB	23.18
EV/EBITDA	N/A

EPS(TTM)-3.47

EYN/A

EPS(NY)-1.04

Fwd EYN/A

FCF(TTM)-1.44

FCFYN/A

OCF(TTM)-1.44

OCFYN/A

SpS0.04

BVpS0.05

TBVpS0.05

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-209.36%
ROE	-2815.04%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	31.54%
FCFM	N/A

ROA(3y)-587.39%

ROA(5y)-528.31%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

F-Score6

Asset Turnover0.06

Health

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	N/A
Cap/Sales	N/A
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	0.96
Quick Ratio	0.96
Altman-Z	-32.97

F-Score6

WACCN/A

ROIC/WACCN/A

Cap/Depr(3y)N/A

Cap/Depr(5y)N/A

Cap/Sales(3y)N/A

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)86.78%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%90.74%

EPS Next Y80.14%

EPS Next 2Y36.61%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)N/A

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%N/A

Revenue Next Year423.66%

Revenue Next 2Y223.69%

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y-30.45%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y-59.88%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-59.88%

OCF growth 3YN/A

OCF growth 5YN/A

SEASTAR MEDICAL HOLDING CORP (ICU) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens